Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation

Liver International

Volumn 27, Issue 6, 2007, Pages 758-763

  Botha, Jean F ^a,c   Thompson, Eric ^a   Gilroy, Richard ^a   Grant, Wendy J ^a   Mukherjee, Sandeep ^a   Lyden, Elizabeth R ^b   Fox, Ira J ^a   Sudan, Debra L ^a   Shaw Jr , Byers W ^a   Langnas, Alan N ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Donor steatosis; HepatitisC; Virus recurrence

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; COLD ISCHEMIA; DISEASE COURSE; DISEASE SEVERITY; DONOR; FATTY LIVER; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; RECURRENT INFECTION; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; COLD ISCHEMIA; DISEASE PROGRESSION; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEBRASKA; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 34447325615     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01490.x     Document Type: Article

References (20)

1. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000; 32: 673-84.
2. Berenguer M. Natural history of recurrent hepatitis C. Liver Transplant 2002; 8 (10): S14-8.
3. Cameron AM, Ghobrial RM, Hiatt JR, et al. Effect of noviral factors on hepatitis C recurrence after liver transplantation. Ann Surg 2006; 244 (4): 563-8.
4. Machicao V, Bonatti H, Krishna M, et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77 (1): 84-92.
5. Tisone G, Manzia T, Zazza S, et al. Marginal donors in liver transplantation. Transplantation Proceedings 2004; 36: 525-6.
6. Imber C, St.Peter S, Handa A, Friend P. Hepatic steatosis and its relationship to transplantation. Liver Transplantation 2002; 8 (5): 415-23.
7. Crowley H, Lewis W, Gordon F, et al. Steatosis in donor and transplant liver biopsies. Human Pathology 2000; 31 (10): 1209-13.
8. Charlton M, Kasparova P, Weston S, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001; 7 (7): 608-14.
9. Markin R, Wisecarver J, Radio S, et al. Frozen section evaluation or donor livers before transplantation. Transplantation 1993; 56 (6): 1403-9.
10. Batts K, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Amer J Pathol 1995; 19 (12): 1409-17.
11. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
12. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28 (3): 823-30.
13. Rodriguez-Luna H, Douglas D. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis 2004; 17: 363-71.
14. Lake J, Shorr J, Steffen B, et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Amer J Transplant 2005; 5: 549-57.
15. Baltz AC, Trotter JF. Living donor liver transplantation and hepatitis C. Clin Liver Dis 2003; 7: 651-65.
16. Firpi R, Abdelmalek M, Soldevila-Pico C, et al. One-year protocol biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transplant 2004; 10 (10): 1240-7.
17. Velidedeoglu E, Mange K, Frank A, et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV-recipients. Transplant 2004; 77 (12): 1834-42.
18. Baron P, Sindram D, Higdon D, et al. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. Liver Transplant 2000; 6 (4): 407-12.
19. Watt KDS, Lyden ER, Gulizia JM, et al. Recurrent hepatitis C posttransplant: Early preservation injury may predict poor outcome. Liver Transplant 2006; 12: 134-9.
20. Ratzui V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-906.